Few STEMI Patients Take Preventive Therapies


Despite the apparently high prevalence of cardiovascular risk factors among patients hospitalized for STEMI without known coronary heart disease (CHD), preventive therapy appears to be low, according findings from to a cohort analysis. Only 24.1% of patients in the analysis were on aspirin, 16.1% were on a statin, and 7.8% were on both. The authors noted that 70% of their STEMI population did not have known CHD before their event, and slightly more than 40% of those events would be considered premature.

Abstract: American Heart Journal, July 18, 2012 (online).

Submit a Comment

Your email address will not be published. Required fields are marked *

sixteen + thirteen =